Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2021 edition) / 中华肿瘤杂志
Chinese Journal of Oncology
;
(12): 591-621, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-887465
ABSTRACT
In China, the incidence and mortality of lung cancer are ranked the first among malignant tumors. In order to further standardize the prevention and treatment measures of lung cancer, improve the prognosis of patients, and provide professional evidence-based medical recommendations to clinical medical staffs, Oncology Society of Chinese Medical Association organized experts from departments of pulmonary medicine, oncology, thoracic surgery, radiotherapy, imaging and pathology, based on the international guidelines and clinical practices in China, integrated the latest evidence-based medical evidences in lung cancer pathology, genetic testing, immune molecular marker detection and treatment methods in recent years. After consensus meetings, the Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer in China was conducted, which provided recommendations of lung cancer screening, diagnosis, pathology, treatment and follow-up to clinicians, imaging, laboratory, and rehabilitation professionals.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
China
/
Consensus
/
Early Detection of Cancer
/
Lung Neoplasms
/
Medical Oncology
Type of study:
Diagnostic study
/
Practice guideline
/
Screening study
Limits:
Humans
Country/Region as subject:
Asia
Language:
Chinese
Journal:
Chinese Journal of Oncology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS